Clinical Trials
892 trialsCZECH-PSMA
General University Hospital, Prague
A Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer
IRCCS San Raffaele
ASCaP
Jonsson Comprehensive Cancer Center
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Jonsson Comprehensive Cancer Center
Frailty in Older Adults With Prostate Cancer: a Prospective Cohort Study
University of Limerick
AWARE
Rigshospitalet, Denmark
IRONMAN
Prostate Cancer Clinical Trials Consortium
CHRU-WCMC
University Hospital, Lille
Hemi-Gland Cryoablation for Prostate Cancer at UCLA
Jonsson Comprehensive Cancer Center
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer
Memorial Sloan Kettering Cancer Center
RECOVER
Comprehensive Cancer Centre The Netherlands
LEARN
University of Sydney
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer
Peking University First Hospital
QUANTIB
IRCCS San Raffaele
High-resolution Intra-operative PSMA PET-CT in Prostate Cancer
IRCCS San Raffaele
Shared Decision Making in Low Risk Prostate Cancer
Massachusetts General Hospital
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
University of Washington
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
Thomas Jefferson University
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
RF-2018-123683
IRCCS San Raffaele
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Massachusetts General Hospital
MP-PET-MRI
IRCCS San Raffaele
PRS-AS
IRCCS San Raffaele
ProsTIC Registry of Men Treated With PSMA Theranostics
Peter MacCallum Cancer Centre, Australia
PARADIGM
University College, London
TA-P-OLIM
University Hospital, Ghent
SELECT
University of Manchester
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Istituto Oncologico Veneto IRCCS
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
LONGEVITI
University of Alberta
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
ABC
University of California, San Francisco
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older
Memorial Sloan Kettering Cancer Center
iCaRe2
University of Nebraska
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Duke University
EVENTIDE
University of Aberdeen
AI-based Measurements of Tumour Burden in PSMA PET-CT
Skane University Hospital
EXO-MET
Xijing Hospital
PSMA-TM
Xijing Hospital
Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
The First Affiliated Hospital of Soochow University
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer
Mayo Clinic
PR3DICT
Maastricht Radiation Oncology
EMUPRO
Elsan
Outcomes of Focal Ablation for Prostate Cancer
University of Texas Southwestern Medical Center
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
Mayo Clinic
CLIQQC
Société Algérienne de Formation et Recherche en Oncologie
HIFU for Focal Ablation of Prostate Tissue: An Observational Study
University of California, Los Angeles